AAAAAA

   
Results: 1-17 |
Results: 17

Authors: Putzi, MJ De Marzo, AM
Citation: Mj. Putzi et Am. De Marzo, Prostate pathology - Histologic and molecular perspectives, HEMAT ONCOL, 15(3), 2001, pp. 407

Authors: Parsons, JK Nelson, CP Gage, WR Nelson, WG Kensler, TW De Marzo, AM
Citation: Jk. Parsons et al., GSTAI expression in normal, preneoplastic, and neoplastic human prostate tissue, PROSTATE, 49(1), 2001, pp. 30-37

Authors: De Marzo, AM
Citation: Am. De Marzo, Gary J. Miller, MD, PhD - In memoriam, PROSTATE, 48(3), 2001, pp. 128-130

Authors: Parsons, JK Gage, WR Nelson, WG De Marzo, AM
Citation: Jk. Parsons et al., p63 protein expression is rare in prostate adenocarcinoma: Implications for cancer diagnosis and carcinogenesis, UROLOGY, 58(4), 2001, pp. 619-624

Authors: Nelson, WG De Marzo, AM DeWeese, TL
Citation: Wg. Nelson et al., The molecular pathogenesis of prostate cancer: Implications for prostate cancer prevention, UROLOGY, 57(4A), 2001, pp. 39-45

Authors: De Marzo, AM Putzi, MJ Nelson, WG
Citation: Am. De Marzo et al., New concepts in the pathology of prostatic epithelial carcinogenesis, UROLOGY, 57(4A), 2001, pp. 103-114

Authors: Nelson, CP Kidd, LCR Sauvageot, J Isaacs, WB De Marzo, AM Groopman, JD Nelson, WG Kensler, TW
Citation: Cp. Nelson et al., Protection against 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine cytotoxicity and DNA adduct formation in human prostate by glutathione S-transferase P1, CANCER RES, 61(1), 2001, pp. 103-109

Authors: Lin, XH Tascilar, M Lee, WH Vles, WJ Lee, BH Veeraswamy, R Asgari, K Freije, D van Rees, B Gage, WR Bova, GS Isaacs, WB Brooks, JD DeWeese, TL De Marzo, AM Nelson, WG
Citation: Xh. Lin et al., GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells, AM J PATH, 159(5), 2001, pp. 1815-1826

Authors: Manley, S Mucci, NR De Marzo, AM Rubin, MA
Citation: S. Manley et al., Relational database structure to manage high-density tissue microarray data and images for pathology studies focusing on clinical outcome - The Prostate Specialized Program of Research Excellence Model, AM J PATH, 159(3), 2001, pp. 837-843

Authors: David-Beabes, GL Overman, MJ Petrofski, JA Campbell, PA De Marzo, AM Nelson, WG
Citation: Gl. David-beabes et al., Doxorubicin-resistant variants of human prostate cancer cell lines DU 145,PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity, INT J ONCOL, 17(6), 2000, pp. 1077-1086

Authors: Tchou, JC Lin, XH Freije, D Isaacs, WB Brooks, JD Rashid, A De Marzo, AM Kanai, Y Hirohashi, S Nelson, WG
Citation: Jc. Tchou et al., GSTP1 CpG island DNA hypermethylation in hepatocellular carcinomas, INT J ONCOL, 16(4), 2000, pp. 663-676

Authors: Putzi, MJ De Marzo, AM
Citation: Mj. Putzi et Am. De Marzo, Morphologic transitions between proliferative inflammatory atrophy and high-grade prostatic intraepithelial neoplasia, UROLOGY, 56(5), 2000, pp. 828-832

Authors: De Marzo, AM Knudsen, B Chan-Tack, K Epstein, JI
Citation: Am. De Marzo et al., E-cadherin expression as a marker of tumor aggressiveness in routinely processed radical prostatectomy specimens, UROLOGY, 53(4), 1999, pp. 707-713

Authors: De Marzo, AM Coffey, DS Nelson, WG
Citation: Am. De Marzo et al., New concepts in tissue specificity for prostate cancer and benign prostatic hyperplasia, UROLOGY, 53(3), 1999, pp. 29-40

Authors: Zhong, H De Marzo, AM Laughner, E Lim, M Hilton, DA Zagzag, D Buechler, P Isaacs, WB Semenza, GL Simons, JW
Citation: H. Zhong et al., Overexpression of hypoxia-inducible factor 1 alpha in common human cancersand their metastases, CANCER RES, 59(22), 1999, pp. 5830-5835

Authors: De Marzo, AM Marchi, VL Yang, ES Veeraswamy, R Lin, XH Nelson, WG
Citation: Am. De Marzo et al., Abnormal regulation of DNA methyltransferase expression during colorectal carcinogenesis, CANCER RES, 59(16), 1999, pp. 3855-3860

Authors: De Marzo, AM Marchi, VL Epstein, JI Nelson, WG
Citation: Am. De Marzo et al., Proliferative inflammatory atrophy of the prostate - Implications for prostatic carcinogenesis, AM J PATH, 155(6), 1999, pp. 1985-1992
Risultati: 1-17 |